BRPI0413428A - xarope seco contendo laratadina - Google Patents

xarope seco contendo laratadina

Info

Publication number
BRPI0413428A
BRPI0413428A BRPI0413428-1A BRPI0413428A BRPI0413428A BR PI0413428 A BRPI0413428 A BR PI0413428A BR PI0413428 A BRPI0413428 A BR PI0413428A BR PI0413428 A BRPI0413428 A BR PI0413428A
Authority
BR
Brazil
Prior art keywords
laratadine
dry syrup
syrup containing
preparations
larated
Prior art date
Application number
BRPI0413428-1A
Other languages
English (en)
Inventor
Toshitada Toyoda
Yoshitsugu Muguruma
Yoshitaka Tomoda
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BRPI0413428A publication Critical patent/BRPI0413428A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"XAROPE SECO CONTENDO LARATADINA". A presente invenção refere-se a preparações de xarope seco contendo laratadina como um fármaco hidrofóbico medicinal. As preparações de xarope seco contendo laratadina são produzidas usando um material celulósico ou um sal de ácido arginínico junto com açúcar.
BRPI0413428-1A 2003-08-08 2004-08-06 xarope seco contendo laratadina BRPI0413428A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003290052A JP3881640B2 (ja) 2003-08-08 2003-08-08 ロラタジンを含むドライシロップ剤
PCT/JP2004/011333 WO2005013991A1 (ja) 2003-08-08 2004-08-06 ロラタジンを含有するドライシロップ

Publications (1)

Publication Number Publication Date
BRPI0413428A true BRPI0413428A (pt) 2006-10-10

Family

ID=34131573

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413428-1A BRPI0413428A (pt) 2003-08-08 2004-08-06 xarope seco contendo laratadina

Country Status (7)

Country Link
US (2) US20080064713A1 (pt)
EP (1) EP1652524A4 (pt)
JP (1) JP3881640B2 (pt)
BR (1) BRPI0413428A (pt)
CA (1) CA2533182A1 (pt)
MX (1) MXPA06001481A (pt)
WO (1) WO2005013991A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1778359B1 (en) * 2004-08-08 2010-10-13 KHAYAT, Eli Pharmaceutical compositions for alleviating excess levels of sugar in diabetic patients
JP2007098390A (ja) * 2005-09-12 2007-04-19 Sanei Gen Ffi Inc 消泡剤
JP5202856B2 (ja) * 2006-03-06 2013-06-05 富山化学工業株式会社 トシル酸トスフロキサシンを含有する粒状固形製剤
CN1820744B (zh) * 2006-04-04 2011-01-26 中国人民解放军军事医学科学院毒物药物研究所 磷酸奥司他韦颗粒剂及其制备方法
JP2009542665A (ja) * 2006-06-29 2009-12-03 シェーリング コーポレイション 糖を含まない保存に安定な抗ヒスタミンシロップ
WO2008098586A1 (en) 2007-02-13 2008-08-21 Dafra Pharma N.V. Pharmaceutical carrier composition and pharmaceutical composition
US9034618B2 (en) * 2009-03-09 2015-05-19 Ineos Bio Sa Method for sustaining microorganism culture in syngas fermentation process in decreased concentration or absence of various substrates
JP2010013357A (ja) * 2008-07-01 2010-01-21 Takada Seiyaku Kk 高含量ｌ−カルボシステインドライシロップ剤
CN102958515A (zh) 2009-12-02 2013-03-06 阿普塔利斯制药有限公司 非索非那定微胶囊及含有非索非那定微胶囊的组合物
KR20120087723A (ko) * 2011-01-28 2012-08-07 제이더블유중외제약 주식회사 건조 시럽 조성물
JO3464B1 (ar) 2013-01-15 2020-07-05 Astellas Pharma Europe Ltd التركيبات الخاصة بمركبات التياكوميسين
CA2948070C (en) * 2014-05-05 2024-02-13 Boehringer Ingelheim International Gmbh Fast dissolving granulate
US10463656B2 (en) 2017-01-05 2019-11-05 Iowa State University Research Foundation, Inc. Methods and compositions for prevention of feedlot bovine respiratory disease
TWI826474B (zh) 2018-06-27 2023-12-21 日商第一三共股份有限公司 包含二胺衍生物之顆粒劑、以及其用途及製造方法
WO2020068484A1 (en) * 2018-09-28 2020-04-02 Dow Global Technologies Llc Hydroxyethyl cellulose derivative foam control agents and methods of processing foodstuffs
KR102193429B1 (ko) 2018-10-26 2020-12-21 서울대학교병원 스마트 펜라이트 및 이를 이용한 동공 반사 분석 시스템

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282233B1 (en) * 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
JPH06157312A (ja) * 1992-11-12 1994-06-03 Shionogi & Co Ltd 苦味改善テルフェナジンドライシロップ顆粒剤
US5455049A (en) * 1995-01-04 1995-10-03 Ascent Pharmaceuticals, Inc. Terfenadine oral powder
US5824339A (en) * 1995-09-08 1998-10-20 Takeda Chemical Industries, Ltd Effervescent composition and its production
JPH09208495A (ja) * 1996-01-26 1997-08-12 Kyorin Pharmaceut Co Ltd 薬物の苦味を低減した粒状製剤及びその製造方法
JP3402195B2 (ja) * 1997-05-14 2003-04-28 千寿製薬株式会社 再分散性の良い水性懸濁液剤
US20030059471A1 (en) * 1997-12-15 2003-03-27 Compton Bruce Jon Oral delivery formulation
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
KR20010089886A (ko) * 1999-10-12 2001-10-12 도리이 신이찌로 경구 의약 조성물
US7223421B2 (en) * 2000-06-30 2007-05-29 Mcneil-Ppc, Inc. Teste masked pharmaceutical particles
IN192160B (pt) * 2000-07-17 2004-02-28 Ranbaxy Lab
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
CN1268337C (zh) * 2002-12-19 2006-08-09 海南普利制药有限公司 地氯雷他定干混悬剂及其制备方法

Also Published As

Publication number Publication date
US20100022577A1 (en) 2010-01-28
US20080064713A1 (en) 2008-03-13
MXPA06001481A (es) 2006-08-23
EP1652524A4 (en) 2012-03-28
EP1652524A1 (en) 2006-05-03
WO2005013991A1 (ja) 2005-02-17
JP2005060265A (ja) 2005-03-10
CA2533182A1 (en) 2005-02-17
JP3881640B2 (ja) 2007-02-14

Similar Documents

Publication Publication Date Title
BRPI0413428A (pt) xarope seco contendo laratadina
BR0208338A (pt) Derivados de piridina
USD601311S1 (en) Bottle shaped pet toy with stopper
BR0207726A (pt) Sais farmacêuticos
BR0214380A (pt) Produto para uso em agricultura ou horticultura
MA28921B1 (fr) Derive heterocyclique azote et medicament le contenant en tant que principe actif
DE60210552D1 (de) Prozess zur Herstellung einer festen pharmazeutischen Zubereitung welche einen schwerlöslichen Wirkstoff enthält
EE200200357A (et) Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
EP1391200A4 (en) DRUG
YU44404A (sh) Postupak za identifikovanje ciljnih enzima tumora
WO2008128775A3 (en) Stabilised pharmaceutical composition containing pregabaline
WO2006137069A3 (en) Balanites aegyptiaca saponins and uses thereof
WO2001089571A3 (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
BR9812553A (pt) Formulação medicamentosa com liberação de substância ativa controlada
WO2007005941A3 (en) Liver targeted conjugates
BRPI0407088A (pt) Produtos n-aril-heteroaromáticos, composições contendo os mesmos e seu uso
BRPI0606520A2 (pt) tripeptìdeo e tetrapeptìdeo tioéteres
BRPI0510259A (pt) formulação cosmética ou dermatológica transparente
BRPI0620229A8 (pt) formulação
EP1961764A4 (en) SUGAR CHAIN ADDUCT OF A PEPTIDE AND PHARMACEUTICAL THAT CONTAINS THIS AS AN ACTIVE SUBSTANCE
BRPI0607614A2 (pt) sal de besilato da 7-(2-(4-3-trifluorometil-fenil)-1,2,3,6-tetrahidropirid- 1-il)etil) isoquinoleìna, o respectivo medicamento, composição farmacêutica e uso
BRPI0518855A2 (pt) medicamento para aplicaÇço higiÊnica no ouvido
FR2912314B1 (fr) Composition pharmaceutique comprenant des anticorps diriges contre l'enveloppe de herv-w.
DE602006017724D1 (de) Salicylsäurederivate
EP1391202A4 (en) LIQUID MEDICINAL PREPARATIONS

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 31/4545, 9/14, 47/10, 47/26, 47/38; A61P 37/08, 11/00

Ipc: A61K 31/4545 (2011.01), A61K 9/14 (2011.01), A61K

B25D Requested change of name of applicant approved

Owner name: MERCK SHARP AND DOHME CORP. (US)

B25G Requested change of headquarter approved

Owner name: MERCK SHARP AND DOHME CORP. (US)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2266 DE 10/06/2014.